CD34 and acute myeloid leukemia: In CD34-negative AML, we standardized the ALDH-MFI values of normal stem cell candidates and CD34– neoplastic cells by dividing these by the ALDH-MFI value of lymphocytes present within the same AML sample (Table S2).